Glenmark Pharmaceuticals has entered into an exclusive licensing deal with Canada-based Immanence-IDC to distribute the latter's anti- aging cosmeticual range of products in eight countries. The company's ten year licensing agreement with Immanence-IDC will span eight countries, including India, Brazil, Mexico, South Africa, Egypt, Vietnam, Malaysia and Thailand. The association would enable the firm to consolidate its leadership position in dermatology across these markets.crackcrack